Homepage banner 1
Product Lines

Explore Our Portfolio

View all categories

Comprehensive Support

Learn More

Exosome Signaling Research Solutions

We provide an end-to-end research platform — from exosome identification markers to cargo analysis and functional communication assays — enabling investigation of extracellular vesicle-mediated signaling networks.

Explore Resources

Ferroptosis Signaling Research Solutions

We provide a comprehensive research platform — from ferroptosis regulatory targets to functional cell death assays — enabling precise investigation of ferroptotic mechanisms.

Explore Resources

Stem Cell Signaling Research Solutions

Comprehensive stem cell signaling research requires integrated analysis of pluripotency networks, developmental pathways, niche-derived signals, metabolic regulation, and epigenetic mechanisms to understand stem cell maintenance, differentiation, regeneration, and disease-associated stemness.

Explore Resources

Immune Checkpoint Signaling Research Solutions

Comprehensive immune checkpoint research requires integrated analysis of checkpoint receptor signaling, T-cell activation and exhaustion states, tumor immune microenvironment composition, antigen presentation mechanisms, and functional immune responses to define mechanisms of immune escape and therapeutic sensitivity. We provide an integrated research solution — from checkpoint signaling targets to immune functional assays — supporting studies of immune regulation and cancer immunotherapy. ## Key Target Highlights ![Core Molecular Targets in Immune Checkpoint Research.webp](https://cms.ucallm.com/uploads/Core_Molecular_Targets_in_Immune_Checkpoint_Research_52d8970152.webp) ### Key research trend: Modern immune checkpoint research is moving beyond individual inhibitory receptors toward a systems-level understanding of immune cell states, tumor microenvironment interactions, antigen presentation, metabolic regulation, and combination therapeutic strategies. Current studies increasingly integrate single-cell sequencing, spatial profiling, and functional immune assays to identify mechanisms of response and resistance to checkpoint blockade therapies. ## Recommended Immune Checkpoint Marker Strategy ![Multi-Level Validation Framework.webp](https://cms.ucallm.com/uploads/Multi_Level_Validation_Framework_8e680138a9.webp) ## Core Immune Checkpoint Validation Strategy ![Golden Pair Concept for Pathway Confirmation.webp](https://cms.ucallm.com/uploads/Golden_Pair_Concept_for_Pathway_Confirmation_d1b29f6e32.webp) ## Competitive Technology Landscape Immune Checkpoint Research Workflow ![Immune Checkpoint Research Workflow.webp](https://cms.ucallm.com/uploads/Immune_Checkpoint_Research_Workflow_4e77d149ef.webp) Immune checkpoint research requires an integrated workflow combining protein validation, immune cell profiling, spatial analysis, functional assessment, molecular characterization, and multi-omics integration. This comprehensive approach enables researchers to understand immune regulation mechanisms, define tumor immune landscapes, and identify predictive biomarkers for immunotherapy response. ## Pathway Overview Immune checkpoint pathways maintain immune balance by regulating T-cell activation, tolerance, and immune responses. Tumors exploit inhibitory pathways such as PD-1/PD-L1 and CTLA-4 to suppress anti-tumor immunity and promote immune escape. Emerging checkpoint pathways, including LAG-3, TIM-3, TIGIT, and VISTA, expand the landscape of immune regulation and immunotherapy research. ![Costimulatory and inhibitory checkpoint pathways..webp](https://cms.ucallm.com/uploads/Costimulatory_and_inhibitory_checkpoint_pathways_8b5ec1683a.webp) ## Recommended Experimental Validation Workflow ![Recommended Experimental Validation Workflow1.webp](https://cms.ucallm.com/uploads/Recommended_Experimental_Validation_Workflow1_a01eaeec64.webp) ![Recommended Experimental Validation Workflow2.webp](https://cms.ucallm.com/uploads/Recommended_Experimental_Validation_Workflow2_781e2ddd63.webp) ## Featured Research Application Examples ![Featured Research Application Examples1.webp](https://cms.ucallm.com/uploads/Featured_Research_Application_Examples1_a3d4744ded.webp) ## Frequently Asked Questions Q1.Which markers should be used to characterize immune checkpoint signaling? Immune checkpoint analysis requires evaluation of both checkpoint molecules and downstream immune signaling pathways. Common checkpoint markers include PD-1 (PDCD1), PD-L1 (CD274), CTLA-4, LAG-3, TIM-3, and TIGIT. Additional markers such as CD3, CD8, CD4, FOXP3, and Granzyme B help define immune cell populations and functional states. Downstream pathway analysis often includes TCR signaling, NFAT, NF-κB, PI3K/AKT, and MAPK pathways to understand checkpoint-mediated immune regulation. Q2. How can researchers evaluate immune checkpoint activation and immune cell function? Immune checkpoint studies should combine expression analysis with functional assays. Common approaches include flow cytometry, immunohistochemistry (IHC), immunofluorescence (IF), and Western blotting to assess checkpoint protein expression and localization. Functional evaluation includes T-cell activation assays, cytokine profiling (IFN-γ, IL-2, TNF-α), cytotoxicity assays, and co-culture systems to determine how checkpoint signaling affects immune responses. Q3. . What are the major signaling pathways involved in immune checkpoint regulation? Immune checkpoints regulate T-cell activation through multiple signaling networks. The PD-1/PD-L1 axis suppresses T-cell activity by recruiting phosphatases such as SHP-2, leading to inhibition of TCR/CD28 signaling, PI3K/AKT, and MAPK pathways. The CTLA-4 pathway regulates early T-cell activation by competing with CD28 for B7 ligands. Additional pathways involving LAG-3, TIM-3, TIGIT, and metabolic regulators contribute to immune exhaustion and tumor immune escape. Q4. What are the common challenges and pitfalls in immune checkpoint research? Major challenges include immune heterogeneity, dynamic checkpoint expression, species differences, and tumor microenvironment complexity. A common pitfall is interpreting checkpoint expression alone as evidence of immune suppression. Researchers should integrate checkpoint profiling, immune cell characterization, functional validation, and appropriate controls to distinguish immune activation, exhaustion, and therapeutic response mechanisms. Q5. How can immune checkpoint research be translated into immunotherapy development? Advanced immune checkpoint studies integrate single-cell sequencing, spatial transcriptomics, multiplex imaging, proteomics, and biomarker analysis to identify immune states and predict therapeutic responses. These approaches support discovery of immune checkpoint biomarkers, combination therapy strategies, and mechanisms of resistance to immune checkpoint inhibitors in cancer and other immune-related diseases. ## Key References 1.Roerden M., Spranger S. (2025).Cancer immune evasion, immunoediting and intratumour heterogeneity.Nature Reviews Immunology. 25:353–369. 2.Zhang Z., Zhang C. (2025).Regulation of cGAS–STING signalling and its diversity of cellular outcomes.Nature Reviews Immunology. 25:425–444. 3.Lotze M.T., Olejniczak S.H., Skokos D. (2024).CD28 co-stimulation: novel insights and applications in cancer immunotherapy.Nature Reviews Immunology. 24(12):878–895. 4.Butterfield L.H., Najjar Y.G. (2024).Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations.Nature Reviews Immunology. 24(6):399–416. 5. Schenkel J.M., Pauken K.E. (2023).Localization, tissue biology and T cell state — implications for cancer immunotherapy.Nature Reviews Immunology. 23:807–823. 6.Hato S.V., Khong A., Fiechter M., et al. (2024).Immune checkpoint blockade: current progress and future directions.Nature Reviews Cancer. 24:585–605. 7.Wei S.C., Duffy C.R., Allison J.P. (2024).Fundamental mechanisms of immune checkpoint blockade therapy.Cancer Discovery. 14:1120–1137. 8.Chauvin J.M., Pagliano O., Fourcade J., et al. (2022).TIGIT and the tumor microenvironment: emerging mechanisms and therapeutic opportunities.Trends in Cancer. 8:914–928.

Explore Resources

Warburg Effect Signaling Research Solutions

Cancer cells undergo extensive metabolic reprogramming to support proliferation, survival, and adaptation to dynamic tumor environments.

Explore Resources

Multiplex Immunohistochemistry Solution for Human colorectal Cancer Organoids

A validated multiplex immunohistochemistry protocol enables simultaneous multi-biomarker spatial analysis on human colorectal cancer organoid models.

Explore Resources

New Arrivals

Learn More

U-Blot® PRG2 rabbit pAb

U-Blot® PRG2 rabbit pAb

View Product

U-Blot® MPP7 rabbit pAb

U-Blot® MPP7 rabbit pAb

View Product

U-Blot® Tuberin (phospho Thr1462) Polyclonal Antibody

U-Blot® Tuberin (phospho Thr1462) Polyclonal Antibody

View Product

U-Blot® Recombinant TNFa (VF0361) Fc-Fused Nanobody

U-Blot® Recombinant TNFa (VF0361) Fc-Fused Nanobody

View Product

U-Blot® Recombinant TNFa (VF0064) Fc-Fused Nanobody

U-Blot® Recombinant TNFa (VF0064) Fc-Fused Nanobody

View Product

U-Blot® Recombinant TIGIT (VF0242) Fc-Fused Nanobody

U-Blot® Recombinant TIGIT (VF0242) Fc-Fused Nanobody

View Product
Learn More

U-Blot® GAPDH Rabbit mAb

U-Blot® GAPDH Rabbit mAb

Learn More

Thin-walled 0.2 mL Individual PCR Tube, with attached Optical Flat cap, Clear

PCR reaction vessels adopt ultra-pure medical-grade polypropylene used in the finest quality molding process to ensure the highest quality tubes, strips, caps, and microplates for PCR.

Learn More

8 Strip PCR Tube, plus strips of Optical flat caps, 0.2ml, clear PP wells, violet PC frame

PCR reaction vessels adopt ultra-pure medical-grade polypropylene used in the finest quality molding process to ensure the highest quality tubes, strips, caps, and microplates for PCR.

Learn More

1536 Well PCR Plate, black

PCR reaction vessels adopt ultra-pure medical-grade polypropylene used in the finest quality molding process to ensure the highest quality tubes, strips, caps, and microplates for PCR.

Learn More

384 well Full skirt PCR plate, 40 µL, white PP wells, black PC frame, A24 Notch

PCR reaction vessels adopt ultra-pure medical-grade polypropylene used in the finest quality molding process to ensure the highest quality tubes, strips, caps, and microplates for PCR.

Learn More

96 well Full skirt PCR plate, 0.1 mL, clear PP wells, yellow PC frame, H1 Notch

PCR reaction vessels adopt ultra-pure medical-grade polypropylene used in the finest quality molding process to ensure the highest quality tubes, strips, caps, and microplates for PCR.

Learn More

Search Products by Molecule Initial

Online Message